Who Supplies Rifampicin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Rifampicin exports, with 175+ registered manufacturers shipping to buyers across 162+ countries — yet a handful of companies dominate the shipments. LUPIN LIMITED holds the largest share at 58.8% (export value: $793.5M). Close behind, MACLEODS PHARMACEUTICALS LTD (24.8%, $334.7M). MACLEODS PHARMACEUTICALS LIMITED (0.5%, $6.9M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Rifampicin? Top Manufacturers & Their Buyers
Flow of Rifampicin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Rifampicin Supplier Network — Key Market Intelligence
The Rifampicin export market from India is led by LUPIN LIMITED, which alone commands a 58.8% share, shipping $793.5M worth of product across 369 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $334.7M (24.8%) to the overall market. Combined, the top two suppliers alone account for 83.6% of all Rifampicin exports, indicating a relatively concentrated supply base.
Across all 175 tracked manufacturers, the total Rifampicin export value stands at $1.3B from 3.9K shipments. The market average shipment value is $344.9K. The single largest buyer relationship in terms of trade value is CAMESKIN/CORDAID, receiving $532.0M worth of product.
The combined buyer network spans 22 named purchasing companies, including CAMESKIN/CORDAID, NATIONAL TUBERCULOSIS AND LEPROSY, UPS SUPPLY CHAIN SOL, I+SOLUTIONS, DEPARTMENT OF HEALTH and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1LUPIN LIMITED
LUPIN LIMITED is the first-largest Rifampicin exporter from India, with a market share of 58.8% and a total export value of $793.5M across 369 shipments. Their average shipment value of $2.2M is above the market average of $344.9K, suggesting premium or bulk contract pricing.
LUPIN LIMITED serves 5 named buyers in our database. CAMESKIN/CORDAID is the dominant customer, accounting for 67.0% of this supplier's tracked business. Top customers include:
• CAMESKIN/CORDAID — $532.0M across 247 shipments (67.0% of this supplier's total exports)
• NATIONAL TUBERCULOSIS AND LEPROSY — $246.7M across 115 shipments (31.1% of this supplier's total exports)
• UPS SUPPLY CHAIN SOL — $7.9M across 4 shipments (1.0% of this supplier's total exports)
• I+SOLUTIONS — $3.5M across 2 shipments (0.4% of this supplier's total exports)
• DEPARTMENT OF HEALTH — $3.4M across 2 shipments (0.4% of this supplier's total exports)
Key Insight: LUPIN LIMITED's per-shipment value of $2.2M is 523% above the market average of $344.9K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Rifampicin exporter from India, with a market share of 24.8% and a total export value of $334.7M across 1.3K shipments. Their average shipment value of $261.5K is below the market average of $344.9K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LA PHARMACIE CENTRALE DE TUNISIE — $144.8M across 554 shipments (43.3% of this supplier's total exports)
• DIRECTOR MBDC DGHS — $87.2M across 333 shipments (26.0% of this supplier's total exports)
• SECRETARY FOR HEALTH AND CHILD CARE — $60.2M across 230 shipments (18.0% of this supplier's total exports)
• NATIONAL PROGRAMME FOR TB — $21.8M across 83 shipments (6.5% of this supplier's total exports)
• MINISTERIO DE SALUD PUBLICA Y — $20.7M across 79 shipments (6.2% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD operates with high shipment frequency (1.3K shipments) at a per-shipment value of $261.5K, indicating a broad distribution network with many smaller, regular orders.
3MACLEODS PHARMACEUTICALS LIMITED
MACLEODS PHARMACEUTICALS LIMITED is the third-largest Rifampicin exporter from India, with a market share of 0.5% and a total export value of $6.9M across 387 shipments. Their average shipment value of $17.8K is below the market average of $344.9K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATIONAL COORDINATOR — $1.9M across 106 shipments (27.5% of this supplier's total exports)
• MACLEODS PHARMACEUTICALS SA — $1.6M across 89 shipments (23.0% of this supplier's total exports)
• MACLEODS PHARMACEUTICALS SA — $1.2M across 67 shipments (17.4% of this supplier's total exports)
• PROGRAMME NATIONAL D — $1.1M across 63 shipments (16.2% of this supplier's total exports)
• THE MINISTRY OF HEAL — $1.1M across 62 shipments (16.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (387 shipments) at a per-shipment value of $17.8K, indicating a broad distribution network with many smaller, regular orders.
4SVIZERA LABS PRIVATE LIMITED
SVIZERA LABS PRIVATE LIMITED is the fourth-largest Rifampicin exporter from India, with a market share of 0.4% and a total export value of $5.4M across 77 shipments. Their average shipment value of $69.7K is below the market average of $344.9K, reflecting a high-volume, competitive pricing strategy.
SVIZERA LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR LABARAN SHEHU — $2.1M across 30 shipments (39.0% of this supplier's total exports)
• NATIONAL TUBERCULOSIS AND LEPROSY — $1.1M across 16 shipments (20.9% of this supplier's total exports)
• MOH NATIONAL TB AND — $906.6K across 13 shipments (16.9% of this supplier's total exports)
• MOH NATIONAL TB AND — $625.4K across 9 shipments (11.7% of this supplier's total exports)
• TO THE ORDER OF — $622.4K across 9 shipments (11.6% of this supplier's total exports)
Key Insight: SVIZERA LABS PRIVATE LIMITED operates with high shipment frequency (77 shipments) at a per-shipment value of $69.7K, indicating a broad distribution network with many smaller, regular orders.
5MANEESH PHARMACEUTICALS LIMITED
MANEESH PHARMACEUTICALS LIMITED is the fifth-largest Rifampicin exporter from India, with a market share of 0.3% and a total export value of $4.1M across 207 shipments. Their average shipment value of $19.7K is below the market average of $344.9K, reflecting a high-volume, competitive pricing strategy.
MANEESH PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• 5 KAMPALA — $1.2M across 59 shipments (28.3% of this supplier's total exports)
• SEKRETARIAT DITJEN PENCEGAHAN DAN P — $790.8K across 40 shipments (19.4% of this supplier's total exports)
• SOCINTER- SOCIEDADE — $745.3K across 38 shipments (18.3% of this supplier's total exports)
• Country Office CO BU — $693.5K across 35 shipments (17.0% of this supplier's total exports)
• KENYA MEDICAL SUPPLIES AGENCY — $692.8K across 35 shipments (17.0% of this supplier's total exports)
Key Insight: MANEESH PHARMACEUTICALS LIMITED operates with high shipment frequency (207 shipments) at a per-shipment value of $19.7K, indicating a broad distribution network with many smaller, regular orders.
6OMNICALS PHARMA PRIVATE LIMITED
OMNICALS PHARMA PRIVATE LIMITED is the fifth-largest Rifampicin exporter from India, with a market share of 0.3% and a total export value of $4.0M across 29 shipments. Their average shipment value of $137.8K is below the market average of $344.9K, reflecting a high-volume, competitive pricing strategy.
OMNICALS PHARMA PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF METR is the dominant customer, accounting for 57.6% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF METR — $2.3M across 17 shipments (57.6% of this supplier's total exports)
• TO THE ORDER OF METR — $1.0M across 8 shipments (25.9% of this supplier's total exports)
• GITTOES PHARMACEUTIC — $438.4K across 3 shipments (11.0% of this supplier's total exports)
• TO THE ORDER OF — $111.8K across 1 shipments (2.8% of this supplier's total exports)
• TO THE ORDER OF — $107.6K across 1 shipments (2.7% of this supplier's total exports)
Key Insight: OMNICALS PHARMA PRIVATE LIMITED operates with high shipment frequency (29 shipments) at a per-shipment value of $137.8K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Rifampicin Flows
Once Rifampicin leaves the manufacturing plants of companies like LUPIN LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $1.3B. Congo Dr absorbs the largest share at 39.7% ($536.0M), followed by Nigeria (18.7%) and Tunisia (10.7%).
In Congo Dr — the top destination — named importers include CAMESKIN/CORDAID. In Nigeria, key buyers are NATIONAL TUBERCULOSIS AND LEPROSY.
This geographic spread reflects Rifampicin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Rifampicin Go? Top Importing Countries & Their Buyers
Trade flow of Rifampicin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Congo Dr
Congo Dr ranks as the first-largest destination for Rifampicin imports from India, with a total trade value of $536.0M across 6 shipments — representing a 39.7% share of all Rifampicin exports. The average shipment value of $89.3M is above the global average of $344.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rifampicin importers in Congo Dr: CAMESKIN/CORDAID is the largest buyer, accounting for 99.3% ($532.5M) of this market's total imports.
• CAMESKIN/CORDAID — $532.5M (99.3% of Congo Dr's total)
Key Insight: Congo Dr's per-shipment average of $89.3M (25800% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Congo Dr is a key market for Rifampicin imports from India.
2Nigeria
Nigeria ranks as the second-largest destination for Rifampicin imports from India, with a total trade value of $252.7M across 67 shipments — representing a 18.7% share of all Rifampicin exports. The average shipment value of $3.8M is above the global average of $344.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rifampicin importers in Nigeria: NATIONAL TUBERCULOSIS AND LEPROSY is the largest buyer, accounting for 98.4% ($248.7M) of this market's total imports.
• NATIONAL TUBERCULOSIS AND LEPROSY — $248.7M (98.4% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $3.8M (994% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Rifampicin imports from India.
3Tunisia
Tunisia ranks as the third-largest destination for Rifampicin imports from India, with a total trade value of $145.1M across 16 shipments — representing a 10.7% share of all Rifampicin exports. The average shipment value of $9.1M is above the global average of $344.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rifampicin importers in Tunisia: LA PHARMACIE CENTRALE DE TUNISIE is the largest buyer, accounting for 99.9% ($144.9M) of this market's total imports.
• LA PHARMACIE CENTRALE DE TUNISIE — $144.9M (99.9% of Tunisia's total)
Key Insight: Tunisia's per-shipment average of $9.1M (2528% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tunisia is a key market for Rifampicin imports from India.
4Bangladesh
Bangladesh ranks as the fourth-largest destination for Rifampicin imports from India, with a total trade value of $96.2M across 22 shipments — representing a 7.1% share of all Rifampicin exports. The average shipment value of $4.4M is above the global average of $344.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Rifampicin importers in Bangladesh: DIRECTOR MBDC DGHS is the largest buyer, accounting for 92.4% ($88.9M) of this market's total imports.
• DIRECTOR MBDC DGHS — $88.9M (92.4% of Bangladesh's total)
• WORLD HEALTH ORGANIZATION (BANGLADE — $4.6M (4.8% of Bangladesh's total)
Key Insight: Bangladesh's per-shipment average of $4.4M (1168% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Bangladesh is a key market for Rifampicin imports from India.
5Zimbabwe
Zimbabwe ranks as the fifth-largest destination for Rifampicin imports from India, with a total trade value of $60.7M across 4 shipments — representing a 4.5% share of all Rifampicin exports. The average shipment value of $15.2M is above the global average of $344.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Rifampicin importers in Zimbabwe: SECRETARY FOR HEALTH AND CHILD CARE is the largest buyer, accounting for 99.4% ($60.4M) of this market's total imports.
• SECRETARY FOR HEALTH AND CHILD CARE — $60.4M (99.4% of Zimbabwe's total)
Key Insight: Zimbabwe's per-shipment average of $15.2M (4302% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Zimbabwe is a key market for Rifampicin imports from India.
People Also Ask — Rifampicin Supplier & Trade Network
Who are the top suppliers of Rifampicin from India?+
Which companies buy Rifampicin from Indian manufacturers?+
Where does Rifampicin exported from India go?+
What is the market share of the top Rifampicin supplier from India?+
What is the average shipment value for Rifampicin exports from India?+
Is Rifampicin manufactured in India and exported globally?+
Which country imports the most Rifampicin from India?+
Who are the buyers of Rifampicin in Nigeria?+
How concentrated is the Rifampicin supplier market in India?+
How do I find verified buyers for Rifampicin in specific countries?+
Rifampicin Trade Network — Key Takeaways
- 1LUPIN LIMITED is India's dominant Rifampicin exporter with a 58.8% market share and $793.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 175 suppliers collectively account for 85.1% of all tracked Rifampicin exports, with a combined trade value of $1.3B.
- 3Congo Dr is the largest destination market, absorbing 39.7% of India's Rifampicin exports ($536.0M). Nigeria (18.7%) and Tunisia (10.7%) follow.
- 4With 3.9K total shipments averaging $344.9K each, the Rifampicin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CAMESKIN/CORDAID, NATIONAL TUBERCULOSIS AND LEPROSY, LA PHARMACIE CENTRALE DE TUNISIE, DIRECTOR MBDC DGHS — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 162 countries
Network value: $1.3B
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Rifampicin.
- 2.Flow Mapping: 175 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,913 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 162 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,913 Verified Shipments
175 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists